Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Nutriband Inc (NQ: NTRB ) 5.300 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 5.300 Bid (Size) 3.900 (1) Ask (Size) 8.470 (1) Prev. Close 5.300 Today's Range 5.300 - 5.300 52wk Range 1.927 - 9.595 Shares Outstanding 6,356,270 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application October 31, 2024 Via ACCESSWIRE Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica October 17, 2024 Via ACCESSWIRE Performance YTD +129.03% +129.03% 1 Month -15.47% -15.47% 3 Month +6.64% +6.64% 6 Month +58.21% +58.21% 1 Year +142.01% +142.01% More News Read More Are Pharma Stocks Harmful To Your Financial Health ? October 09, 2024 Via Talk Markets BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Schedules Live Investor Webinar, Q&A Session October 02, 2024 Via Investor Brand Network Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17 October 02, 2024 Via ACCESSWIRE BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Announces Receipt of Notice of Allowance for China Patent Application Covering AVERSA(TM) Technology September 24, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property NTRB Stock Earnings: Nutriband Reported Results for Q1 2024 June 25, 2024 Via InvestorPlace As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse September 24, 2024 Via FinancialNewsMedia Exposures Product Safety As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse September 24, 2024 From FN Media Group LLC Via GlobeNewswire NUTRIBAND RECEIVES CHINA PATENT NOTICE OF ALLOWANCE FOR ITS AVERSA™ ABUSE DETERRENT TRANSDERMAL TECHNOLOGY September 24, 2024 Via FinancialNewsMedia Topics Intellectual Property Exposures Intellectual Property Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology September 24, 2024 Via ACCESSWIRE BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Inks Licensing Agreement to Use Bitrex(R) Aversive Agent for Flagship Product September 20, 2024 Via Investor Brand Network Women Reach Settlement After Yale Nurse Switched Painkillers with Saline Solution September 20, 2024 Via Investor Brand Network Topics Lawsuit Exposures Financial Legal Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch September 20, 2024 Via ACCESSWIRE BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Reports on Share Repurchase Program September 17, 2024 Via Investor Brand Network Microsoft, Intel And 3 Stocks To Watch Heading Into Tuesday September 17, 2024 Via Benzinga Nutriband Inc. Authorizes $1M Share Buyback Program September 16, 2024 Via ACCESSWIRE BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Releases Q2 Report, AVERSA Fentanyl Update September 04, 2024 Via Investor Brand Network Exposures Product Safety Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025 September 04, 2024 Via ACCESSWIRE Proposed US Law Would Direct Opioid Settlement Cash to Opioid Crisis Management August 28, 2024 Via Investor Brand Network BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Execs to Participate in July 25 Investor Webinar July 19, 2024 Via Investor Brand Network Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25 July 19, 2024 Via ACCESSWIRE BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Obtains Notice of Allowance for Key Trademark Identified as ‘Integral’ to Platform Technology July 15, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology July 15, 2024 Via ACCESSWIRE BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Shares Update on Its AVERSA(TM) Fentanyl Product Development Program June 20, 2024 Via Investor Brand Network Exposures Product Safety Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
